Professional Documents
Culture Documents
RESUMEN
According to the news reporters, the research concluded: "Nevertheless, target achievement rates of each, and of
all three, quality indicators were suboptimal, indicating there are still unmet needs in the management of T2DM."
TEXTO COMPLETO
2017 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Health &Medicine Week -- Research findings on
Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes are discussed in a new report. According to
news reporting from Ioannina, Greece, by NewsRx journalists, research stated, "To investigate the effect of
benchmarking on the quality of type 2 diabetes (T2DM) care in Greece. The OPTIMISE (Optimal Type 2 Diabetes
Management Including Benchmarking and Standard Treatment) study [ClinicalTrials.gov identifier: NCT00681850]
was an international multicenter, prospective cohort study."
The news correspondents obtained a quote from the research from the University of Ioannina, "It included
physicians randomized 3:1 to either receive benchmarking for glycated hemoglobin (HbA1c), systolic blood
pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) treatment targets (benchmarking group) or not
(control group). The proportions of patients achieving the targets of the above-mentioned parameters were
compared between groups after 12 months of treatment. Also, the proportions of patients achieving those targets
at 12 months were compared with baseline in the benchmarking group. In the Greek region, the OPTIMISE study
included 797 adults with T2DM (570 in the benchmarking group). At month 12 the proportion of patients within the
predefined targets for SBP and LDL-C was greater in the benchmarking compared with the control group (50.6
versus 35.8%, and 45.3 versus 36.1%, respectively). However, these differences were not statistically significant.
No difference between groups was noted in the percentage of patients achieving the predefined target for HbA1c.
At month 12 the increase in the percentage of patients achieving all three targets was greater in the benchmarking
(5.9-15.0%) than in the control group (2.7-8.1%). In the benchmarking group more patients were on target regarding
SBP (50.6% versus 29.8%), LDL-C (45.3% versus 31.3%) and HbA1c (63.8% versus 51.2%) at 12 months compared
with baseline (p <0.001 for all comparisons). Benchmarking may comprise a promising tool for improving the
quality of T2DM care."
DETALLES
Lugar: Greece
Identificador / palabra Ioannina Greece Europe Diabetes Management Non Insulin Dependent Diabetes
clave: Mellitus Nutritional and Metabolic Diseases and Conditions Risk and Prevention
Type 2 Diabetes
Título: Nutritional and Metabolic Diseases and Conditions - Type 2 Diabetes; New Type 2
Diabetes Study Findings Have Been Reported by Researchers at University of
Ioannina [Effects of benchmarking on the quality of type 2 diabetes care: results of
the OPTIMISE (Optimal Type 2 Diabetes Management Including Benchmarking ... ]
Editorial: NewsRx
ISSN: 15316459
e-ISSN: 15324605
Copyright de la base de datos 2021 ProQuest LLC. Reservados todos los derechos.